Odyssey completes $6.3m capital raise to support distribution growth

Odyssey Wellness – creator of Odyssey Elixir sparkling energy drink – has completed a $6.3 million Series A capital raise that will support Elixir’s growth across all its distribution channels.

Odyssey Elixir is “the first” sparkling energy drink infused with functional mushrooms. Each beverage contains 2,500mg of fruiting body extracts from functional mushrooms (cordyceps and lion’s mane), as well as L-theanine and panax ginseng, which provide the benefits of nootropics, adaptogens and beta-glucans.

The beverages are said to promote brain performance and boost energy, focus and mood, without the caffeine crash, artificial sweeteners, added sugar, or other ingredients associated with traditional energy drinks.

Scott Frohman, founder and CEO of Odyssey Wellness, commented: “Odyssey is a purpose-driven company on a mission to upgrade people from their habitual caffeine crash, jitters and burnout to a more sustainable energy. By utilising the power of functional mushrooms and bringing them mainstream, we aspire to expand a growing population of conscious individuals that are more focused, more productive, and passionate about doing good, feeling good, and sharing those vibes with others.”

He added: “We appreciate the infusion of capital and trust from our investors who bring incredible expertise and will be valuable strategic partners as we continue to build this brand.”

Since its debut last year, it is now available at over 5,000 brick-and-mortar locations, including natural and conventional retailers.